PA
CORV

Perceptive Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Perceptive Advisors’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000,000
Closed -$2M – 130
2019
Q3 		$2M Buy
+1,000,000
New +$2.03M 0.05% 82

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Perceptive Advisors's CORV Position: Q4 2019 in Review

Perceptive Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 1,000,000 shares — an estimated $2M sold.

Perceptive Advisors first reported a position in CORV in Q3 2019 and held it in 1 quarter. The position peaked at $2M in Q3 2019. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Perceptive Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Perceptive Advisors sold 1,000,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $2M.
  • Perceptive Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2019 and held it in 1 quarter.
  • Perceptive Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $2M in Q3 2019.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.